|
Lung
|   |
Lung (SLUNR)
- For resection specimens (including wedge resections, segmentectomies, lobectomies and pneumonectomies) with any type of carcinoma or carcinoid tumor
Specimen and Surgical Procedure
Specimen, laterality, procedure......................................................
Lymph nodes submitted and/or identified in the specimen................... yes/no
Tumor
Tumor site...................................................................................
Tumor focality................................................. unifocal/multifocal/cannot be determined
(if multifocal, specify if separate tumor nodules are in the same lobe or
different lobes and/or whether synchronous carcinomas are present)
Tumor size...................................................................................
Histologic type* ...........................................................................
Histologic grade............................................................................
Visceral pleural invasion....................................... present/absent/cannot be determined
Classify as present if
- tumor is present at pleural surface and/or
- tumor penetrates through pleural elastic layer (on elastic stain)
Tumor extension** .....................................................................
Lymph-vascular invasion.............................................................. present/absent
Tumor-associated atelectasis or obstructive pneumonitis...................
Classify as one of the following
- Not identified
- Present; extends to the hilar region but does not involve entire lung
- Present; involves entire lung
Treatment effect...........................................................................
Classify as one of the following
- N/A
- Cannot be determined
- >10% residual viable tumor
- <10% residual viable tumor
Final Margins
Nearest margin............................................................................
Distance from specified margin to tumor.........................................
Bronchial margin........................................... positive/negative/NA/cannot be assessed
Carcinoma in situ at margin................................................. present/absent
Vascular margin............................................ positive/negative/NA/cannot be assessed
Parenchymal margin...................................... positive/negative/NA/cannot be assessed
Other margin(s) (if applicable; please specify)....positive/negative/NA/cannot be assessed
Lymph Nodes
Number of peribronchial nodes (involved/examined) .......................... __/__
Other lymph nodes (list each group separately by site)....................... __/__
Pathologic stage........................................................................ pT__N__M__